Compared with the control group, adjudin-treated mice displayed significantly greater numbers of NeuN+/BrdU+ and CD31+/BrdU+ cells at 35 days after tMCAO in the perifocal striatum region (Figures 6A–D), indicating that adjudin promoted neurogenesis and angiogenesis from ischemic stroke induced impairments. Here, RBFOX3 is linked to ischemic stroke.